*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Europe Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

Europe generic injectables market is currently witnessing strong growth. Generic injectables refer to alternative drugs that are equivalent to their branded counterparts in terms of the dosage, quality, strength, performance, and intended use. Generic injectables are beneficial in treating various life-threatening and chronic diseases, such as cancer, diabetes, rheumatoid arthritis, cardiovascular ailments, and respiratory infections. They aim to maximize patient compliance and reduce the frequency of administered dosage, thereby maintaining the effectiveness of the treatment.

The increasing prevalence of chronic diseases across Europe represents the key factor driving the market growth. In line with this, intravenous (IV) and intramuscular (IM) routes of drug administration are gaining widespread preference in the healthcare sector for fast drug delivery and for treating patients that are incapable of taking oral doses of medication. This is contributing to the market growth in the region significantly. Additionally, generic injectables are cost-effective as compared to branded drugs, which is acting as another growth-inducing factor. Apart from this, the increasing shortage of medicines and expiry of patents of branded items, are further creating a positive outlook for the market in Europe. On account of these factors, the market is expected to continue its strong in the forecast period (2021-2026).

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the Europe generic injectables market report, along with forecasts for growth at the region level from 2021-2026. Our report has categorized the market based on region, therapeutic area, container and distribution channel.

Breakup by Therapeutic Area:

  • Oncology
  • Anaesthesia
  • Anti-infectives
  • Parenteral Nutrition
  • Cardiovascular
     

Breakup by Container:

  • Vials
  • Ampoules
  • Premix
  • Prefilled Syringes
     

Breakup by Distribution Channel:

  • Hospitals
  • Retail Pharmacy
     

Breakup by Country:

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Report Coverages:

Report Features Details
Base Year of the Analysis 2020
 Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Million
Segment Coverage Therapeutic Area, Container, Distribution Channel, Country
Countries Covered Germany, France, United Kingdom, Italy, Spain
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the Europe generic injectables market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Europe generic injectables market?
  • What are the key regional markets?
  • What is the breakup of the market based on the therapeutic area?
  • What is the breakup of the market based on the container?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the Europe generic injectables market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Europe Generic Injectables Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market by Therapeutic Area
    6.1    Oncology
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Anaesthesia
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Anti-infectives
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Parenteral Nutrition
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Cardiovascular
        6.5.1 Market Trends
        6.5.2 Market Forecast
7    Market by Container
     7.1    Vials
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Ampoules
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Premix
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Prefilled Syringes
        7.4.1 Market Trends
        7.4.2 Market Forecast
8    Market by Distribution Channel
     8.1    Hospitals
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Retail Pharmacy 
        8.2.1 Market Trends
        8.2.2 Market Forecast
9    Market Breakup by Country
    9.1    Germany
        9.1.1 Market Trends
        9.1.2 Market Breakup by Therapeutic Area
        9.1.3 Market Breakup by Container
        9.1.4 Market Breakup by Distribution Channel
        9.1.5 Market Forecast
    9.2    France
        9.2.1 Market Trends
        9.2.2 Market Breakup by Therapeutic Area
        9.2.3 Market Breakup by Container
        9.2.4 Market Breakup by Distribution Channel
        9.2.5 Market Forecast
    9.3    United Kingdom
        9.3.1 Market Trends
        9.3.2 Market Breakup by Therapeutic Area
        9.3.3 Market Breakup by Container
        9.3.4 Market Breakup by Distribution Channel
        9.3.5 Market Forecast
    9.4    Italy
        9.4.1 Market Trends
        9.4.2 Market Breakup by Therapeutic Area
        9.4.3 Market Breakup by Container
        9.4.4 Market Breakup by Distribution Channel
        9.4.5 Market Forecast
    9.5    Spain
        9.5.1 Market Trends
        9.5.2 Market Breakup by Therapeutic Area
        9.5.3 Market Breakup by Container
        9.5.4 Market Breakup by Distribution Channel
        9.5.5 Market Forecast
    9.6    Others
        9.6.1 Market Trends
        9.6.2 Market Breakup by Therapeutic Area
        9.6.3 Market Breakup by Container
        9.6.4 Market Breakup by Distribution Channel
        9.6.5 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Policy and Regulatory Landscape
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players

List of Figures

Figure 1: Europe: Generic Injectables Market: Major Drivers and Challenges
Figure 2: Europe: Generic Injectables Market: Sales Value (in Million US$), 2015-2020
Figure 3: Europe: Generic Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 4: Europe: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2020
Figure 5: Europe: Generic Injectables Market: Breakup by Container (in %), 2020
Figure 6: Europe: Generic Injectables Market: Breakup by Distribution Channel (in %), 2020
Figure 7: Europe: Generic Injectables Market: Breakup by Country (in %), 2020
Figure 8: Europe: Generic Injectables (Oncology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Europe: Generic Injectables (Oncology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Europe: Generic Injectables (Anaesthesia) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Europe: Generic Injectables (Anaesthesia) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Europe: Generic Injectables (Anti-infectives) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Europe: Generic Injectables (Anti-infectives) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Europe: Generic Injectables (Parenteral Nutrition) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Europe: Generic Injectables (Parenteral Nutrition) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Europe: Generic Injectables (Cardiovascular) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Europe: Generic Injectables (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Europe: Generic Injectables (Vials) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Europe: Generic Injectables (Vials) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Europe: Generic Injectables (Ampoules) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Europe: Generic Injectables (Ampoules) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Europe: Generic Injectables (Premix) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Europe: Generic Injectables (Premix) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Europe: Generic Injectables (Prefilled Syringes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Europe: Generic Injectables (Prefilled Syringes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Europe: Generic Injectables (Hospitals) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Europe: Generic Injectables (Hospitals) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Europe: Generic Injectables (Retail Pharmacy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Europe: Generic Injectables (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Germany: Generic Injectables Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Germany: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2020
Figure 32: Germany: Generic Injectables Market: Breakup by Container (in %), 2020
Figure 33: Germany: Generic Injectables Market: Breakup by Distribution Channel (in %), 2020
Figure 34: Germany: Generic Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: France: Generic Injectables Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: France: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2020
Figure 37: France: Generic Injectables Market: Breakup by Container (in %), 2020
Figure 38: France: Generic Injectables Market: Breakup by Distribution Channel (in %), 2020
Figure 39: France: Generic Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: United Kingdom: Generic Injectables Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: United Kingdom: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2020
Figure 42: United Kingdom: Generic Injectables Market: Breakup by Container (in %), 2020
Figure 43: United Kingdom: Generic Injectables Market: Breakup by Distribution Channel (in %), 2020
Figure 44: United Kingdom: Generic Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Italy: Generic Injectables Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: Italy: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2020
Figure 47: Italy: Generic Injectables Market: Breakup by Container (in %), 2020
Figure 48: Italy: Generic Injectables Market: Breakup by Distribution Channel (in %), 2020
Figure 49: Italy: Generic Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Spain: Generic Injectables Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Spain: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2020
Figure 52: Spain: Generic Injectables Market: Breakup by Container (in %), 2020
Figure 53: Spain: Generic Injectables Market: Breakup by Distribution Channel (in %), 2020
Figure 54: Spain: Generic Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Others: Generic Injectables Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Others: Generic Injectables Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: Europe: Generic Injectables Industry: SWOT Analysis
Figure 58: Europe: Generic Injectables Industry: Value Chain Analysis
Figure 59: Europe: Generic Injectables Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Europe: Generic Injectables Market: Key Industry Highlights, 2020 and 2026
Table 2: Europe: Generic Injectables Market Forecast: Breakup by Therapeutic Area (in Million US$), 2021-2026
Table 3: Europe: Generic Injectables Market Forecast: Breakup by Container (in Million US$), 2021-2026
Table 4: Europe: Generic Injectables Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 5: Europe: Generic Injectables Market Forecast: Breakup by Country (in Million US$), 2021-2026
Table 6: Europe: Generic Injectables Market: Competitive Structure
Table 7: Europe: Generic Injectables Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links